Purchases and Sales Made in Q4 2022 in Eucrates Biomedical Acquisition Corp. (EUCR)
This table provides information about the institutional ownership of Eucrates Biomedical Acquisition Corp. (EUCR) during Q4 2022. The information is specifically focused on institutions that hold shares of Eucrates Biomedical Acquisition Corp..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
BUY
|
- |
21.9KNew |
$216K - $219K
|
21.9K
$0
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-330- 33.43% |
$3.26K - $3.3K
|
657
$0
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-434- 11.08% |
$4.28K - $4.34K
|
3.48K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Old Mission Capital LLC
|
SELL
|
- |
-15.8K- 98.58% |
$156K - $158K
|
228
$0
|